Remember me

[ ]
Go to site

Project Objectives

The main objective of this project is to develop a research network including private and public institutions focused on the exchange of expertise in imaging, genomics and bioinformatics to be utilized in monitoring therapies and disease progression in severe allergic asthma (AA).
The main scientific and technological objectives are:
  • Development of novel optical imaging techniques and genomic biomarkers for severe AA
  • Identification of potential biomarkers useful for clinical monitoring of therapeutic efficacy of novel compounds in the treatment of severe AA
  • Development of novel high resolution imaging techniques in animal models of AA
  • Bioinformatics support in the acquisition, management, archiving, and analysis of imaging and genomics data

Approach & Methodology

P³AGI will investigate AA through an interdisciplinary approach which stems form the partners' complementary competences and instrumentation available; this will involve the following methodologies:
  • Development of Novel Optical Imaging Procedures specific to AA
  • Optical Imaging Methods in AA Models
  • Monitoring severe allergic asthma in Hu-SCID mouse models of AA
  • Genomics, bioinformatics, data and knowledge management
Given the complementarity of these steps, an intense scheme of staff secondments, training and networking activities and new recruitments has been planned in order to ensure that public and private partners share the best competences available for the joint achievement of P³AGI objective: a thorough understanding of AA and the exploration of its possible treatment.

Further information: Technologies and Workpackages description

Search P3AGI
Site Translator
Upcoming Events
There are no events scheduled in the next 150 days

The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7 (2007-2013)) under grant no. 230739